Programme

Lecture Theatre 1B
2022-09-03
15:50-17:05
State Key Lab Meeting (1) - Molecular mechanisms of GI cancer
15:50
Genetic and epigenetic alterations in gastric cancer
16:10
Mettl3 as a therapeutic target in colorectal cancer
16:30
Dual function of MEN1 in modulating colon cancer tumor-microenvironment interactions
16:50
Q & A
Lecture Theatre 1B
2022-09-03
17:05-18:20
State Key Lab Meeting (2) - Microbiome/metabolites, gut-liver axis and liver diseases
17:05
Enterically derived HDL restrains liver injury through the portal vein
17:25
Intestine gene regulates NAFLD through gut-liver axis
17:45
Fecal mycobiome in NAFLD
18:05
Q & A
Lecture Theatre 1B
2022-09-04
09:00-10:30
State Key Lab Meeting (3) - Microbiome and host response
09:00
Microbiome in GI cancer
09:25
Genetic stability and individual specificity of the human gut microbiome
09:50
The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinoma
10:15
Q & A
Lecture Theatre 1B
2022-09-04
11:00-12:30
State Key Lab Meeting (4) - Microbiome and cancer therapy
11:00
Microbiome and anti-cancer therapy
11:25
Enterococcus and cancer immunotherapy
11:50
Targeting microbiome for cancer prevention/treatment
12:15
Q & A
Lecture Theatre 1A
2022-09-04
14:30-16:00
COVID-19 and the GUT: lessons learnt
14:30
Gut microbiome and vaccine response
14:55
COVID-19 vaccine and immunosuppressants: chicken or egg?
15:20
Balancing your gut microbiome to fight COVID-19: what’s the evidence?
15:45
Q & A
State Key Lab Meeting (1) - Molecular mechanisms of GI cancer
Lecture Theatre 1B
2022-09-03
15:50
15:50
Genetic and epigenetic alterations in gastric cancer
16:10
Mettl3 as a therapeutic target in colorectal cancer
16:30
Dual function of MEN1 in modulating colon cancer tumor-microenvironment interactions
16:50
Q & A
State Key Lab Meeting (2) - Microbiome/metabolites, gut-liver axis and liver diseases
Lecture Theatre 1B
2022-09-03
17:05
17:05
Enterically derived HDL restrains liver injury through the portal vein
17:25
Intestine gene regulates NAFLD through gut-liver axis
17:45
Fecal mycobiome in NAFLD
18:05
Q & A
State Key Lab Meeting (3) - Microbiome and host response
Lecture Theatre 1B
2022-09-04
09:00
09:00
Microbiome in GI cancer
09:25
Genetic stability and individual specificity of the human gut microbiome
09:50
The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinoma
10:15
Q & A
State Key Lab Meeting (4) - Microbiome and cancer therapy
Lecture Theatre 1B
2022-09-04
11:00
11:00
Microbiome and anti-cancer therapy
11:25
Enterococcus and cancer immunotherapy
11:50
Targeting microbiome for cancer prevention/treatment
12:15
Q & A
COVID-19 and the GUT: lessons learnt
Lecture Theatre 1A
2022-09-04
14:30
14:30
Gut microbiome and vaccine response
14:55
COVID-19 vaccine and immunosuppressants: chicken or egg?
15:20
Balancing your gut microbiome to fight COVID-19: what’s the evidence?
15:45
Q & A